As global markets navigate a mix of rising stock indices and declining consumer confidence, investors are increasingly focused on strategies that offer stability amidst economic uncertainty. In this environment, dividend stocks can provide a reliable income stream, making them an attractive option for those looking to balance growth with consistent returns.

Click here to see the full list of 1942 stocks from our Top Dividend Stocks screener.

Here we highlight a subset of our preferred stocks from the screener.

Simply Wall St Dividend Rating: ★★★★☆☆

Overview: Dubai Refreshment (P.J.S.C.) is involved in the bottling and selling of Pepsi Cola International products across Dubai, Sharjah, and the Northern Emirates of the UAE, with a market cap of AED2.16 billion.

Operations: The company's revenue primarily comes from the wholesale of groceries, amounting to AED808.51 million.

Dividend Yield: 3.3%

Dubai Refreshment (P.J.S.C.) presents a mixed dividend picture. While dividends are covered by earnings and cash flows with payout ratios at 56.6% and 45.1%, respectively, the dividend yield of 3.33% is below top-tier levels in the AE market. The company's dividend payments have been volatile over the past decade but show growth trends despite an unreliable track record. Recent earnings showed a decline in net income, impacting potential future payouts amidst illiquid shares and internal discussions underway.

Simply Wall St Dividend Rating: ★★★★☆☆

Overview: BioGaia AB (publ) is a healthcare company that offers probiotic products globally, with a market cap of SEK11.32 billion.

Operations: BioGaia AB (publ) generates revenue primarily from its Pediatrics segment, which accounts for SEK1.04 billion, and its Adult Health segment, contributing SEK306.08 million.

Dividend Yield: 6.2%

BioGaia's dividend yield is among the top 25% in Sweden, yet its sustainability is questionable due to high cash payout ratios of 191.2%, indicating dividends aren't well-covered by cash flows. Despite a reasonable earnings payout ratio of 57%, past decade payments have been volatile and unreliable. Recent earnings reveal decreased net income, which may affect future payouts despite ongoing product innovations like BioGaia® Gastrus® PURE ACTION aimed at expanding market reach and improving digestive health solutions.